Fan Difu, Song Leming, Xie Donghua, Hu Min, Peng Zuofeng, Liao Xiaohui, Liu Tairong, Du Chuance, Zhu Lunfeng, Yao Lei, Huang Jianrong, Yang Zhongsheng, Guo Shulin, Qin Wen, Zhong Jiuqing, Ye Zhangqun
Department of Urology, The Affiliated Ganzhou City People's Hospital of Nanchang University, Ganzhou, Jiangxi, 341000, China.
Dermatology Institute of Gan County, Jiangxi, 341100, China.
BMC Urol. 2015 Oct 13;15:102. doi: 10.1186/s12894-015-0097-3.
There are still disagreements on which is a better approach to choose to establish percutaneous tract for percutaneous nephrolitotomy (PCNL), between supracostal and infracostal approaches. The aim of this study is to investigate the safety, efficacy and practicability of minimally invasive PCNL (MPCNL) with the aid of a patented system either through supracostal or through infracostal access.
A retrospective study was carried out for 83 patients with renal or upper ureteral stones. Under the guidance of B ultrasound or C-arm, these patients were treated by MPCNL through either 12th rib infracostal (Group 1, 43 cases) or supracostal (Group 2, 40 cases) access approach. These 2 groups were compared for total number of percutaneous tracts, average time in establishing a given percutaneous tract, the number of percutaneous tract used for each case, the average stone clearance time, the clearance rate of all stones by one surgery, and the amount of bleeding using a single percutaneous tract.
There was a significantly smaller total number of percutaneous tracts needed, a smaller number of cases that needed two percutaneous tracts to clear stones completely, a shorter average time in establishing a percutaneous tract, and a smaller average amount of bleeding in infracostal access group. At the same time, there were a significantly larger number of cases in which stones were cleared completely using a single percutaneous tract and a higher renal stone clearance rate by one surgery.
There were several advantages of infracostal access. These included accuracy in establishing a percutaneous tract, safety, quickness, convenience and flexibility in moving the patented sheath, and higher renal and upper ureteral stone clearance rate by one surgery.
在经皮肾镜取石术(PCNL)建立经皮通道的两种方法中,即肋上入路和肋下入路,哪种方法更好仍存在争议。本研究的目的是探讨借助专利系统通过肋上或肋下入路进行微创经皮肾镜取石术(MPCNL)的安全性、有效性和实用性。
对83例肾或上段输尿管结石患者进行回顾性研究。在B超或C臂引导下,这些患者通过第12肋肋下入路(第1组,43例)或肋上入路(第2组,40例)接受MPCNL治疗。比较两组的经皮通道总数、建立单个经皮通道的平均时间、每例使用的经皮通道数量、平均结石清除时间、一次手术的结石完全清除率以及单个经皮通道的出血量。
肋下入路组所需的经皮通道总数明显较少,需要两个经皮通道才能完全清除结石的病例数较少,建立经皮通道的平均时间较短,平均出血量较少。同时,使用单个经皮通道完全清除结石的病例数明显较多,一次手术的肾结石清除率较高。
肋下入路有几个优点。这些优点包括建立经皮通道的准确性、安全性、快速性、在移动专利鞘时的便利性和灵活性,以及一次手术较高的肾和上段输尿管结石清除率。